Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Drug Metabol Drug Interact. 2013;28(1):23–30. doi: 10.1515/dmdi-2012-0038

Figure 2. Association between CYP2C19*17 genotype and total CYP2C19 expression.

Figure 2

CYP2C19*17 heterozygotes and homozygous were associated with 1.8-fold (p=0.028) and 2.9-fold (p=0.006) increases in CYP2C19 mRNA, respectively. Data are presented as a box plot and whisker plot (box shows median with the 25th and 75th percentiles), and minimum and maximum values are shown by whiskers. Outliers that do not fall within the bounds of the plot and that are greater than three box-heights are indicated with ○ and *, respectively